Chapter 1. OPIOIDS MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. OPIOIDS MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

 2.3.1. Impact during 2023 - 2030

  2.3.2. Impact on Supply – Demand

Chapter 3. OPIOIDS MARKET –  Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. OPIOIDS MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. OPIOIDS MARKET -  Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. OPIOIDS MARKET – By Product Type

6.1. Codeine

6.2.Fentanyl

6.3. Hydrocodone

6.4. Methadone

6.5. Morphine

6.6. Oxycodone

6.7. Others

6.8.  Codeine

6.9. Fentanyl

6.10. Hydrocodone

6.11. Methadone

6.12. Morphine

6.13.Oxycodone

6.14. Others

Chapter 7. OPIOIDS MARKET – By Application

7.1. Cough Treatment

7.2. Diarrhea Treatment

7.3. Pain Management

Chapter 8. OPIOIDS MARKET – By Region

8.1. North America

8.2. Europe

8.3. Asia - Pacific

8.4. Latin America

8.5. The Middle East

8.6. Africa

Chapter 9. OPIOIDS MARKET – By Companies

9.1. Company 1

9.2. Company 2

9.3. Company 3

9.4. Company 4

9.5. Company 5

9.6. Company 6

9.7. Company 7

9.8. Company 8

9.9. Company 9

9.10. Company 10

Download Sample